Enhance Your TIL Expansion

With tumor-infiltrating lymphocytes (TIL) therapy exhibiting significant promise against a diverse range of solid tumors, it is crucial to develop a dependable method for expanding TIL cultures in therapeutic development. Largely comprised of T cells, TILs are actively engaged within the tumor microenvironment and can either suppress or activate immune responses.

Better expansion and greater consistency in your TIL cultures will accelerate your progress in ongoing studies and enable your TIL therapy to reach the patients who need it. In this application note, you will learn how organoids can aid in the evaluation of TIL-tumor cell interactions and facilitate the comparison of expansion media.